D. Stypinski

发表

Dosimetry estimations for 123I-IAZA in healthy volunteers.

S. McQuarrie, A. McEwan, Y. Tam, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pivotal Considerations for Optimal Deployment of Healthy Volunteers in Oncology Drug Development

Weiwei Tan, N. Drezner, Whitney S. Helms, 2019, Clinical and translational science.

Clinical pharmacokinetics of 123I-IAZA in healthy volunteers.

A. McEwan, Y. Tam, L. Wiebe, 1999, Nuclear medicine communications.

Effects of Rifampin, a Potent Inducer of Drug‐Metabolizing Enzymes and an Inhibitor of OATP1B1/3 Transport, on the Single Dose Pharmacokinetics of Anacetrapib

Yang Liu, D. Gutstein, J. Cote, 2013, Journal of clinical pharmacology.

Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.

J. Wagner, Yang Liu, R. Krishna, 2012, British Journal of Clinical Pharmacology.

Lack of an effect of anacetrapib on the pharmacokinetics of digoxin in healthy subjects.

J. Wagner, Yang Liu, R. Krishna, 2011, Biopharmaceutics & drug disposition.

Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects.

H. Schmidli, G. Lefèvre, P. Carpenter, 2002, British journal of clinical pharmacology.

Moderate Hepatic Impairment Does Not Affect Doravirine Pharmacokinetics

K. Lasseter, T. Marbury, K. Yee, 2017, Journal of clinical pharmacology.

Pharmacokinetics of SPECT radiopharmaceuticals for imaging hypoxic tissues.

L. Wiebe, D. Stypinski, 1996, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

A rapid and simple assay to determine the blood and urine concentrations of 1-(5-[123/125I]iodo-5-deoxyarabinofuranosyl)-2-nitroimidazole, a hypoxic cell marker.

L. Wiebe, J. Mercer, D. Stypinski, 1998, Journal of pharmaceutical and biomedical analysis.

A Single‐Dose, Two‐Way Crossover, Bioequivalence Study of Dexmethylphenidate HCl with and without Food in Healthy Subjects

D. Stirling, A. Wu, D. Stypinski, 2004, Journal of clinical pharmacology.

Fluoroazomycin arabinoside (FAZA): synthesis, 2H and 3H‐labelling and preliminary biological evaluation of a novel 2‐nitroimidazole marker of tissue hypoxia

H. Machulla, A. McEwan, Piyush Kumar, 1999 .

Absence of clinically relevant drug-drug interaction between odanacatib and digoxin after concomitant administration.

J. Wagner, A. Mehta, S. Stoch, 2013, International journal of clinical pharmacology and therapeutics.

Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors

M. Galsky, A. Bardia, C. Chappey, 2022, JAMA oncology.

Metabolism, Excretion, and Pharmacokinetics of Lorlatinib (PF-06463922) and Evaluation of the Impact of Radiolabel Position and Other Factors on Comparability of Data Across 2 ADME Studies.

T. R. Johnson, A. Vaz, Y. Pithavala, 2020, Journal of clinical pharmacology.

A Contract Research Organization's Response to the New FDA Guidances for Bioequivalence/Bioavailability Studies for Orally Administered Drug Products

Mark Stiles, M. Stiles, Ebi Kimanani, 2000, Journal of clinical pharmacology.

Abstract P1-19-03: JAVELIN PARP Medley, a phase 1b/2 study of avelumab plus talazoparib: Results from advanced breast cancer cohorts

M. Galsky, A. Bardia, C. Chappey, 2020 .

Effects of methoxyflurane anesthesia on the pharmacokinetics of 125I-IAZA in Sprague-Dawley rats.

A. McEwan, Y. Tam, L. Wiebe, 1999, Nuclear medicine and biology.

Coadministration of Rifampin Significantly Reduces Odanacatib Concentrations in Healthy Subjects

M. Reitman, F. Kesisoglou, A. Mehta, 2017, Journal of clinical pharmacology.

Radiation Dosimetry of Theragnostic Pairs for Isotopes of Iodine in IAZA

S. McQuarrie, A. McEwan, H. Jans, 2022, Pharmaceutics.

Drug Interactions with Colesevelam Hydrochloride, a Novel, Potent Lipid-Lowering Agent

M. Stiles, S. Burke, D. Stypinski, 2000, Cardiovascular Drugs and Therapy.

Lack of Interaction between Modified-Release Fluvastatin and Amlodipine in Healthy Subjects

D. Stypinski, L. Gonasun, P. Prasad, 2004, Clinical drug investigation.

Safety, tolerability and pharmacokinetics of higher-dose mizoribine in healthy male volunteers.

D. Stypinski, M. Obaidi, H. Ishikawa, 2007, British journal of clinical pharmacology.

Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A

W. Zeng, R. Railkar, X. Chu, 2017, Clinical pharmacology and therapeutics.

Pharmacokinetics and Scintigraphic Imaging of the Hypoxia-Imaging Agent [123I]IAZA in Healthy Adults Following Exercise-Based Cardiac Stress †

S. McQuarrie, A. McEwan, L. Wiebe, 2018, Pharmaceutics.

Pharmacokinetics of the Hypoxia-Imaging Agent [123I]IAZA in Healthy Adults Following Exercise-Based Cardiac Stress

S. McQuarrie, A. McEwan, L. Wiebe, 2017 .

Pharmacokinetics and Scintigraphic Imaging of the 2 Hypoxia-Imaging Agent [ 123 I ] IAZA in Healthy Adults 3 following Exercise-Based Cardiac Stress 4 Short title : [ 123 I ] IAZA Pharmacokinetics and Imaging 5 following Cardiac Stress 6

S. McQuarrie, A. McEwan, L. Wiebe, 2018 .

Absence of Food Effect on the Extent of Alprazolam Absorption from an Orally Disintegrating Tablet

M. Stiles, D. Stypinski, K. Erdman, 2007, Pharmacotherapy.